top banner imagetop banner mobile image

2017 Press Releases
Print Page  | E-mail Page  | RSS Feeds  | E-mail Alerts  | IR Contacts  | Financial Tear Sheet 

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
05/23/17TherapeuticsMD Announces Presentation at Jefferies 2017 Healthcare Conference on June 8Printer Friendly Version
05/10/17TherapeuticsMD Announces Presentation at Bank of America Merrill Lynch 2017 Healthcare Conference on May 16Printer Friendly Version
05/08/17TherapeuticsMD Receives Complete Response Letter from FDA for TX-004HR New Drug ApplicationPrinter Friendly Version
05/02/17TherapeuticsMD to Host TX-004HR Regulatory Update Conference Call and Webcast on May 8Printer Friendly Version
05/02/17TherapeuticsMD Announces First Quarter 2017 Financial ResultsPrinter Friendly Version
04/19/17TherapeuticsMD Provides Additional Information on TX-004HR Regulatory UpdatePrinter Friendly Version
04/10/17TherapeuticsMD Provides TX-004HR Regulatory UpdatePrinter Friendly Version
04/03/17TherapeuticsMD Presents Positive Phase 3 Data in Two Presentations for TX-001HR at ENDO 2017Printer Friendly Version
03/16/17TherapeuticsMD Announces Presentation at the Oppenheimer 27th Annual Healthcare Conference on March 22Printer Friendly Version
03/03/17TherapeuticsMD Announces Presentation at Cowen and Company 37th Annual Healthcare Conference on March 7Printer Friendly Version
02/23/17TherapeuticsMD Announces Fourth Quarter and Full-Year 2016 Financial ResultsPrinter Friendly Version
02/15/17TherapeuticsMD Announces Webcast of Investor Day on March 1Printer Friendly Version
02/09/17TherapeuticsMD to Host Fourth Quarter and Year End 2016 Financial Results Conference Call and Webcast on February 23Printer Friendly Version
01/19/17TherapeuticsMD Announces Investor Day on March 1Printer Friendly Version
01/11/17TherapeuticsMD Announces Publication of Two Manuscripts on the Rejoice Trial for TX-004HR in Leading Peer-Reviewed Medical JournalPrinter Friendly Version
01/03/17TherapeuticsMD to Present at 35th Annual J.P. Morgan Healthcare Conference on January 11Printer Friendly Version

CORPORATE PRESENTATION

 

PRIMARY TXMD CONTACTS

David DeLucia
Director, Investor Relations
TherapeuticsMD
6800 Broken Sound Parkway NW
3rd Floor
Boca Raton, FL 33487
561-961-1900 or
david.delucia@therapeuticsmd.com